Director – Pan Tumor & Safety Medical Lead – WW Medical Oncology – Rare Tumors

Director – Pan Tumor & Safety Medical Lead – WW Medical Oncology – Rare Tumors

Requirements

• Life sciences and/or healthcare professional training with an advanced degree is required (MD, PharmD, PhD).
• Minimum of 5+ years working in the pharmaceutical industry (Medical Affairs/Medical Strategy, Clinical Research) with experience in Oncology therapeutic area is preferred.
• Strong analytical skills, strong scientific data interpretation + contextualization and ability to work effectively with cross functional teams including clinical, commercialization, regulatory, HEOR and Access.
• Excellent strategy development, critical thinking, decision making and demonstrated ability to successfully create and implement both short and long-range plans.
• Entrepreneurial thinking, anticipates needs, assesses and manages business and organizational risks.
• Highly organized and motivated and possess excellent people management, interpersonal, and strong communication skills, both verbal and written.

Responsibilities

• Shaping global medical strategy with the cross functional team around key assets in scope.
• Ensuring assigned assets are appropriately (co-)positioned and developed within the overall BMS disease area strategy in line with enterprise needs.
• In line with Medical Product Leads and Disease Area Head direction, develop and execute the global medical strategy, scientific narratives, provide medical insight for Global Program Teams, commercial strategic plans, and provide strategic direction in medical communication efforts to ensure delivery of key knowledge to the internal stakeholders including local medical market colleagues; ensure alignment across global markets on medical strategy.
• Responsible for developing asset/indication Integrated Evidence Plans – Lead workstreams to identify evidence gaps to address unmet needs and to define and support global execution of these opportunities. Develop prioritized Integrated Evidence Plans that conform to the Medical Value Framework for execution across modalities including Investigator sponsored research, Medical Affairs Sponsored Trials, RWD and Clinical Research Collaborations.
• Collaborate with Medical Communications leads for the overall successful delivery of Global Medical Communications plans – Ensure workstreams are optimized in generating impactful strategies with respect to the medical communication plans including publications, scientific symposia, global independent medical education, internal training strategy as well as into commercialization brand plans.
• Provide medical support for governance meetings, tumor CDTs and GPT, lead congresses execution, and advisory board meeting planning and execution; provide medical input for development of booths, congress materials, and standard response letters; and work with MedComms to support the execution of medcomms tactics (abstracts, manuscripts, and congress presentations).
• Partner closely with medical colleagues in the Markets, with Clinical Research, Regulatory, Commercial, Access, Health Outcomes, Publications, and other key functions.
• Cross collaborate with other disease area team members that have scope in tumor overlap to advise on development strategy as well as alignment overall with disease area strategy.
• Provide program highlights/updates to Department and/or corporate leadership as requested.
• Maintain ongoing long-term collaborative peer-to-peer relationships with key global thought leaders and oversight over activities, including Advisory Boards, congress encounters, symposia speaking engagements and alignment with markets/other cross functional partners to ensure efficient and impactful KOL collaboration.
• Focus and engage with high impact external influencers/thought leaders to identify and translate key insights and to shape development of BMS pipeline.
• Develop impactful managed access programs for pre-launch assets to ensure inclusive access to our medicines in a equitable manner globally, where permitted.
• Ensure allocated budget and resources are appropriately spent to plan and consistent with business needs and in compliance with policies.
• Ability to lead across teams and direct resources appropriately to manage the deliverables for the asset/indication across disease areas in alignment with GPT priorities.

Preferred Qualifications

• Experience in Oncology therapeutic area is preferred.